Edaravone protect against retinal damage in streptozotocin-induced diabetic mice

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Yuan, Dongqing ^a   Xu, Yidan ^a   Hang, Hui ^a   Liu, Xiaoyi ^a   Chen, Xi ^a   Xie, Ping ^a   Yuan, Songtao ^a   Zhang, Weiwei ^a   Lin, Xiaojun ^a   Liu, Qinghuai ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CASPASE 3; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NORPHENAZONE; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR ERG; PHENAZONE; PHENYLMETHYLPYRAZOLONE; SCAVENGER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CELL DEATH; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE COURSE; DOWN REGULATION; ELECTRORETINOGRAPHY; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; EYE PROTECTION; MALE; MOUSE; NERVE DEGENERATION; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; RETINA GANGLION CELL; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; COMPLICATION; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; PATHOLOGY; RETINAL DISEASES; WESTERN BLOTTING;

ANIMALS; ANTIPYRINE; BLOTTING, WESTERN; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; ELECTRORETINOGRAPHY; FREE RADICAL SCAVENGERS; MALE; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RETINAL DISEASES; RETINAL GANGLION CELLS;

EID: 84902492411     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099219     Document Type: Article

References (35)

1. Ola MS, Nawaz MI, Siddiquei MM, Al-Amro S, Abu El-Asrar AM (2012) Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy. J Diabetes Complications 26: 56-64.
2. Kowluru RA, Chan PS (2007) Oxidative stress and diabetic retinopathy. Exp Diabetes Res 2007: 1-12. (ID: 43603, http://dx.doi.org/10.1155/2007/43603).
3. Carmody RJ, Cotter TG (2000) Oxidative stress induces caspase-independent retinal apoptosis in vitro. Cell Death Differ 7: 282-291. (Pubitemid 30192977)
4. Toyoda K, Fujii K, Kamouchi M, Nakane H, Arihiro S, et al. (2004) Free radical scavenger, edaravone, in stroke with internal carotid artery occlusion. J Neurol Sci 221: 11-17. (Pubitemid 38721285)
5. Nishi H, Watanabe T, Sakurai H, Yuki S, Ishibashi A (1989) Effect of MCI-186 on brain edema in rats. Stroke 20: 1236-1240. (Pubitemid 19226920)
6. Imai S, Inokuchi Y, Nakamura S, Tsuruma K, Shimazawa M, et al. (2010) Systemic administration of a free radical scavenger, edaravone, protects against light-induced photoreceptor degeneration in the mouse retina. Eur J Pharmacol 642: 77-85.
7. Aizu Y, Oyanagi K, Hu J, Nakagawa H (2002) Degeneration of retinal neuronal processes and pigment epithelium in the early stage of the streptozotocin-diabetic rats. Neuropathology 22: 161-170. (Pubitemid 35252706)
8. Shimazaki H, Hironaka K, Fujisawa T, Tsuruma K, Tozuka Y, et al. (2011) Edaravone-loaded liposome eyedrops protect against light-induced retinal damage in mice. Invest Ophthalmol Vis Sci 52: 7289-7297.
9. Inokuchi Y, Imai S, Nakajima Y, Shimazawa M, Aihara M, et al. (2009) Edaravone, a free radical scavenger, protects against retinal damage in vitro and in vivo. J Pharmacol Exp Ther 329: 687-698.
10. Cheng HX, Yuan ST, Liu QH (2012) Recording method of mouse pattern electroretinogram. Chin J Exp Ophthalmol 30: 50-53.
11. Li W, Xu H, Hu Y, He P, Ni Z, et al. (2013) Edaravone protected human brain microvascular endothelial cells from methylglyoxal-induced injury by inhibiting AGEs/RAGE/oxidative stress. PLoS One 8: e76025.
12. Li GY, Fan B, Su GF (2009) Acute energy reduction induces caspase-dependent apoptosis and activates p53 in retinal ganglion cells (RGC-5). Exp Eye Res 89: 581-589.
13. Ji Y, Lu G, Chen G, Huang B, Zhang X, et al. (2011) Microcystin-LR Induces Apoptosis via NF-kappaB/iNOS Pathway in INS-1 Cells. Int J Mol Sci 12: 4722-4734.
14. Yang Y, Mao D, Chen X, Zhao L, Tian Q, et al. (2012) Decrease in retinal neuronal cells in streptozotocin-induced diabetic mice. Mol Vis 18: 1411-1420.
15. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, et al. (1998) Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 102: 783-791. (Pubitemid 28399611)
16. Zeng XX, Ng YK, Ling EA (2000) Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats. Vis Neurosci 17: 463-471.
17. Qin Y, Xu G, Wang W (2006) Dendritic abnormalities in retinal ganglion cells of three-month diabetic rats. Curr Eye Res 31: 967-974.
18. Scott TM, Foote J, Peat B, Galway G (1986) Vascular and neural changes in the rat optic nerve following induction of diabetes with streptozotocin. J Anat 144: 145-152. (Pubitemid 16124886)
19. Zheng L, Howell SJ, Hatala DA, Huang K, Kern TS (2007) Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy. Diabetes 56: 337-345.
20. Seigel GM, Lupien SB, Campbell LM, Ishii DN (2006) Systemic IGF-I treatment inhibits cell death in diabetic rat retina. J Diabetes Complications 20: 196-204.
21. Sima AA, Zhang WX, Cherian PV, Chakrabarti S (1992) Impaired visual evoked potential and primary axonopathy of the optic nerve in the diabetic BB/W-rat. Diabetologia 35: 602-607.
22. Kusari J, Zhou S, Padillo E, Clarke KG, Gil DW (2007) Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats. Invest Ophthalmol Vis Sci 48: 5152-5159. (Pubitemid 351260926)
23. El-Remessy AB, Al-Shabrawey M, Khalifa Y, Tsai NT, Caldwell RB, et al. (2006) Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes. Am J Pathol 168: 235-244. (Pubitemid 43062576)
24. Hall ED, Detloff MR, Johnson K, Kupina NC (2004) Peroxynitrite-mediated protein nitration and lipid peroxidation in a mouse model of traumatic brain injury. J Neurotrauma 21: 9-20. (Pubitemid 38141798)
25. Lewen A, Matz P, Chan PH (2000) Free radical pathways in CNS injury. J Neurotrauma 17: 871-890.
26. Seki M1, Nawa H, Fukuchi T, Abe H, Takei N (2003) BDNF is upregulated by postnatal development and visual experience: quantitative and immunohistochemical analyses of BDNF in the rat retina. Invest Ophthalmol Vis Sci 44: 3211-3218.
27. Martin KR1, Quigley HA, Zack DJ, Levkovitch-Verbin H, Kielczewski J, et al (2003) Gene therapy with brain-derived neurotrophic factor as a protection: retinal ganglion cells in a rat glaucoma model. Invest Ophthalmol Vis Sci 44: 4357-4365.
28. Amemiya S, Kamiya T, Nito C, Inaba T, Kato K, et al. (2005) Anti-apoptotic and neuroprotective effects of edaravone following transient focal ischemia in rats. Eur J Pharmacol 516: 125-130. (Pubitemid 40799348)
29. Lee BJ, Egi Y, van Leyen K, Lo EH, Arai K (2010) Edaravone, a free radical scavenger, protects components of the neurovascular unit against oxidative stress in vitro. Brain Res 1307: 22-27.
30. Roh MI, Murakami Y, Thanos A, Vavvas DG, Miller JW (2011) Edaravone, an ROS scavenger, ameliorates photoreceptor cell death after experimental retinal detachment. Invest Ophthalmol Vis Sci 52: 3825-3831.
31. Miloso M, Scuteri A, Foudah D, Tredici G (2008) MAPKs as mediators of cell fate determination: an approach to neurodegenerative diseases. Curr Med Chem 15: 538-548. (Pubitemid 351516810)
32. Luo Y, DeFranco DB (2006) Opposing roles for ERK1/2 in neuronal oxidative toxicity: distinct mechanisms of ERK1/2 action at early versus late phases of oxidative stress. J Biol Chem 281: 16436-16442.
33. Kawasaki T, Kitao T, Nakagawa K, Fujisaki H, Takegawa Y, et al. (2007) Nitric oxide-induced apoptosis in cultured rat astrocytes: protection by edaravone, a radical scavenger. Glia 55: 1325-1333. (Pubitemid 47328936)
34. Sasaki M1, Ozawa Y, Kurihara T, Kubota S, Yuki K, et al (2010) Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes. Diabetologia 53: 971-979.
35. Silva KC1, Rosales MA, Biswas SK, Lopes de Faria JB, Lopes de Faria JM (2009) Diabetic retinal neurodegeneration is associated with mitochondrial oxidative stress and is improved by an angiotensin receptor blocker in a model combining hypertension and diabetes. Diabetes 58: 1382-1390.